Vinay K. Puduvalli

8.9k total citations · 1 hit paper
170 papers, 4.6k citations indexed

About

Vinay K. Puduvalli is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vinay K. Puduvalli has authored 170 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 61 papers in Molecular Biology and 50 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vinay K. Puduvalli's work include Glioma Diagnosis and Treatment (105 papers), Brain Metastases and Treatment (41 papers) and Histone Deacetylase Inhibitors Research (18 papers). Vinay K. Puduvalli is often cited by papers focused on Glioma Diagnosis and Treatment (105 papers), Brain Metastases and Treatment (41 papers) and Histone Deacetylase Inhibitors Research (18 papers). Vinay K. Puduvalli collaborates with scholars based in United States, Canada and Switzerland. Vinay K. Puduvalli's co-authors include Kenneth R. Hess, Mark R. Gilbert, Morris D. Groves, Deepa Sampath, Victor A. Levin, W.K. Alfred Yung, Pierre Giglio, Charles A. Conrad, Howard Colman and Athanassios P. Kyritsis and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and Blood.

In The Last Decade

Vinay K. Puduvalli

160 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor microenvironment in glioblastoma: Current and emerging concepts

2023 166 citations Pratibha Sharma, Ashley Aaroe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vinay K. Puduvalli United States	38	2.2k	1.9k	1.2k	1.1k	934	170	4.6k
Joon H. Uhm United States	37	2.1k 0.9×	1.7k 0.9×	1.1k 0.9×	764 0.7×	907 1.0×	127	4.4k
M. Kelly Nicholas United States	26	2.8k 1.2×	1.6k 0.8×	1.1k 0.9×	1.2k 1.1×	863 0.9×	64	4.5k
Akitake Mukasa Japan	29	1.9k 0.9×	2.3k 1.2×	1.4k 1.1×	725 0.7×	883 0.9×	179	5.2k
Yoshitaka Narita Japan	37	2.6k 1.2×	2.0k 1.0×	1.2k 0.9×	1.2k 1.1×	1.3k 1.4×	234	5.6k
Dietmar Krex Germany	32	2.2k 1.0×	2.1k 1.1×	1.1k 0.9×	946 0.9×	558 0.6×	84	4.5k
W.K. Alfred Yung United States	40	3.1k 1.4×	2.9k 1.5×	1.3k 1.0×	1.4k 1.3×	1.4k 1.5×	108	5.9k
Mathilde C.M. Kouwenhoven Netherlands	33	3.1k 1.4×	1.7k 0.9×	1.5k 1.2×	1.3k 1.2×	793 0.8×	99	5.2k
Patrick N. Harter Germany	38	1.5k 0.7×	1.9k 1.0×	971 0.8×	655 0.6×	1.2k 1.3×	181	4.8k
W. K. Alfred Yung United States	33	1.5k 0.7×	2.3k 1.2×	1.1k 0.9×	690 0.6×	1.2k 1.3×	80	4.2k
Ghazaleh Tabatabai Germany	38	2.7k 1.2×	1.9k 1.0×	1.0k 0.8×	926 0.8×	836 0.9×	183	5.3k

Countries citing papers authored by Vinay K. Puduvalli

Since Specialization

Citations

This map shows the geographic impact of Vinay K. Puduvalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinay K. Puduvalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinay K. Puduvalli more than expected).

Fields of papers citing papers by Vinay K. Puduvalli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinay K. Puduvalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinay K. Puduvalli. The network helps show where Vinay K. Puduvalli may publish in the future.

Co-authorship network of co-authors of Vinay K. Puduvalli

This figure shows the co-authorship network connecting the top 25 collaborators of Vinay K. Puduvalli. A scholar is included among the top collaborators of Vinay K. Puduvalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinay K. Puduvalli. Vinay K. Puduvalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puduvalli, Vinay K., et al.. (2025). Diversity of metabolic features and relevance to clinical subtypes of gliomas. Seminars in Cancer Biology. 112. 126–134. 1 indexed citations

Sharma, Pratibha & Vinay K. Puduvalli. (2024). Protocol for real-time assessment of mitochondrial and glycolytic ATP production in patient-derived glioma stem-like cells. STAR Protocols. 5(3). 103159–103159.

García, Catherine, et al.. (2024). Single center experience of IDH inhibitors in high-grade gliomas.. Journal of Clinical Oncology. 42(16_suppl). e14036–e14036.

Wen, Patrick Y., et al.. (2024). MGMT promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma. Neuro-Oncology. 26(12). 2388–2390. 2 indexed citations

Sharma, Pratibha, et al.. (2024). DDDR-30. ENHANCED CHEMO AND RADIO-SENSITIZATION OF GLIOMAS BY HSP90 INHIBITION WITH JIN-001, A NOVEL BLOOD-BRAIN BARRIER PENETRANT HSP90 INHIBITOR. Neuro-Oncology. 26(Supplement_8). viii132–viii132. 1 indexed citations

Rixe, Olivier, John L. Villano, Robert Wesolowski, et al.. (2024). A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade Gliomas. Clinical Cancer Research. 30(22). 5053–5060. 1 indexed citations

Liang, Jiyong, Dexing Fang, Joy Gumin, et al.. (2023). A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers. 15(4). 1085–1085. 1 indexed citations

Pilat, Mary Jo, Derek Shyr, Yu Shyr, et al.. (2023). Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer Research Communications. 3(2). 192–201. 18 indexed citations

Harrison, Rebecca A., Nazanin Majd, Margaret Johnson, et al.. (2023). Characterization of industry relationships in oncology. Cancer. 129(18). 2848–2855.

10.

Majd, Nazanin, D.N. Yeboa, Shiao‐Pei Weathers, et al.. (2023). CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_5). v84–v84. 1 indexed citations

11.

Sharma, Pratibha, Alessandro Canella, Alessandra M. Welker, et al.. (2022). Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. Clinical Cancer Research. 28(9). 1979–1990. 18 indexed citations

12.

Özer, Hatice Gülçin, Pierluigi Gasparini, Giovanni Nigita, et al.. (2022). HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia. Blood Advances. 7(12). 2897–2911. 7 indexed citations

13.

Puduvalli, Vinay K. & Hoang Duc Nguyen. (2018). Chemotherapy of High-Grade Astrocytomas in Adults. Progress in neurological surgery. 31. 116–144. 5 indexed citations

14.

Nabar, G. M., Catherine Czeisler, Vinay K. Puduvalli, et al.. (2018). Micelle-templated, poly(lactic-<em>co</em>-glycolic acid) nanoparticles for hydrophobic drug delivery. International Journal of Nanomedicine. Volume 13. 351–366. 22 indexed citations

15.

Canella, Alessandro, Alessandra M. Welker, Ji Young Yoo, et al.. (2017). Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. Clinical Cancer Research. 23(20). 6215–6226. 52 indexed citations

16.

Geng, Feng, Xiang Cheng, Xiaoning Wu, et al.. (2016). Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis. Clinical Cancer Research. 22(21). 5337–5348. 244 indexed citations

17.

Pierson, Christopher R., Kristin Huntoon, Oleksandr N. Kryvenko, et al.. (2015). Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One WithBRAF^V600EMutation and Clinical Response to theBRAFInhibitor Dabrafenib. Journal of Neuropathology & Experimental Neurology. 74(10). 960–969. 28 indexed citations

18.

Xu, Jihong, Deepa Sampath, Frederick F. Lang, et al.. (2011). Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. Journal of Neuro-Oncology. 105(2). 241–251. 37 indexed citations

19.

Giglio, Pierre, Kenneth R. Hess, Mark R. Gilbert, et al.. (2011). Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 118(14). 3599–3606. 12 indexed citations

20.

Wick, Wolfgang, Vinay K. Puduvalli, Marc C. Chamberlain, et al.. (2010). Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma. Journal of Clinical Oncology. 28(7). 1168–1174. 359 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact